Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Latest From Virobay, Inc.

BioNotebook: Two deals, two offerings, seven IPO updates

Bind couples with Merck; Idera connects with DMD patients; Mast, CTI BioPharma price offerings; and three companies prices IPOs, including INC Research, a CRO.

Gastrointestinal Cardiovascular

IPO TABLE: Biotech slides even after strong offerings

Biotechnology companies launched half of the initial public offerings completed by venture capital-backed companies in 2014, but the momentum behind the IPO boom is slowing.

Gastrointestinal Immune Disorders

Deals Shaping The Medical Industry, October 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced August-September 2014.

BioPharmaceutical Medical Device

IPO TABLE: Five biotech offerings coming soon after Affimed priced, eight others filed or set terms

The market for initial public offerings has been especially frothy for biotechnology companies during the past two years and the week of 15 to 19 September may illustrate perfectly the strange dichotomy at work in the IPO space.

Gastrointestinal Metabolic Disorders
See All

Company Information

  • Industry
  • Biotechnology